Researchers showed that elevated SRPX2 in gastric cancer and pancreatic ductal adenocarcinoma enhanced migration and adhesion through increasing phosphorylation levels of FAK [27, 34]. This evidence concerns the gene SRPX2 and pancreatic ductal adenocarcinoma.